Diandric triploid hydatidiform mole with loss of maternal chromosome 11

American Journal of Surgical Pathology

Volumn 35, Issue 10, 2011, Pages 1586-1591

  DeScipio, Cheryl ^a,b   Haley, Lisa ^a   Beierl, Katie ^a   Pandit, Ashwini P ^c,d   Murphy, Kathleen M ^a,e   Ronnett, Brigitte M ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b DEPARTMENT OF PATHOLOGY   (United States)

^c ObGyn Women's Care PC   (United States)

^d HOLY CROSS HOSPITAL   (United States)

^e ProPath   (United States)

Author keywords

hydatidiform mole; immunohistochemistry; molecular genotype; p57

Indexed keywords

CDKN1C PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1C;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 11; CHROMOSOME DELETION; CLASSIFICATION; DIFFERENTIAL DIAGNOSIS; ECHOGRAPHY; FEMALE; GENETICS; HUMAN; HYDATIDIFORM MOLE; PELVIS; PREGNANCY; TRIPLOIDY; UTERUS CANCER;

ADULT; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 11; CYCLIN-DEPENDENT KINASE INHIBITOR P57; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; HYDATIDIFORM MOLE; PELVIS; PREGNANCY; TRIPLOIDY; UTERINE NEOPLASMS;

EID: 80053379764     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31822d5cff     Document Type: Article

References (20)

1. Bifulco C, Johnson C, Hao L, et al. Genotypic analysis of hydatidiform mole: an accurate and practical method of diagnosis. Am J Surg Pathol. 2008;32:445-451 (Pubitemid 351398937)
2. Castrillon DH, Sun D, Weremowicz S, et al. Discrimination of complete hydatidiform mole from its mimics by immunohistochemistry of the paternally imprinted gene product p57KIP2. Am J Surg Pathol. 2001;25:1225-1230 (Pubitemid 32917114)
3. Chilosi M, Piazzola E, Lestani M, et al. Differential expression of p57kip2, a maternally imprinted cdk inhibitor, in normal human placenta and gestational trophoblastic disease. Lab Invest. 1998; 78:269-276 (Pubitemid 28128890)
4. Crisp H, Burton JL, Stewart R, et al. Refining the diagnosis of hydatidiform mole: image ploidy analysis and p57KIP2 immunohistochemistry. Histopathology. 2003;43:363-373 (Pubitemid 37249150)
5. Feltmate CM, Growdon WB, Wolfberg AJ, et al. Clinical characteristics of persistent gestational trophoblastic neoplasia after partial hydatidiform molar pregnancy. J Reprod Med. 2006;51: 902-906 (Pubitemid 44788839)
6. Fisher RA, Nucci MR, Thaker HM, et al. Complete hydatidiform mole retaining a chromosome 11 of maternal origin: molecular genetic analysis of a case. Mod Pathol. 2004;17:1155-1160 (Pubitemid 39128243)
7. Fukunaga M. Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles. Hum Pathol. 2002;33: 1188-1192 (Pubitemid 36020068)
8. Fukunaga M. Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med. 2004;128:897-900 (Pubitemid 39014124)
9. Hoffner L, Dunn J, Esposito N, et al. P57KIP2 immunostaining and molecular cytogenetics: combined approach aids in diagnosis of morphologically challenging cases with molar phenotype and in detecting androgenetic cell lines in mosaic/chimeric conceptions. Hum Pathol. 2008;39:63-72 (Pubitemid 350216161)
10. Jun SY, Ro JY, Kim KR. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles. Histopathology. 2003;43:17-25 (Pubitemid 36836583)
11. McConnell TG, Murphy KM, Hafez M, et al. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach. Am J Surg Pathol. 2009;33: 805-817
12. McConnell TG, Norris-Kirby A, Hagenkord JM, et al. Complete hydatidiform mole with retained maternal chromosomes 6 and 11. Am J Surg Pathol. 2009;33:1409-1415
13. Murphy KM, McConnell TG, Hafez MJ, et al. Molecular genotyping of hydatidiform moles: analytic validation of a multiplex short tandem repeat assay. J Mol Diagn. 2009;11: 598-605
14. Popiolek DA, Yee H, Mittal K, et al. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole. Hum Pathol. 2006; 37:1426-1434 (Pubitemid 44584331)
15. Redline RW, Hassold T. Zaragoza MV. Prevalence of the partial molar phenotype in triploidy of maternal and paternal origin. Hum Pathol. 1998;29:505-511 (Pubitemid 28213471)
16. Ronnett BM, DeScipio C, Murphy KM. Hydatidiform moles: ancillary techniques to refine diagnosis. Int J Gynecol Pathol. 2011; 30:101-116
17. Sebire NJ, Fisher RA, Foskett M, et al. Risk of recurrent hydatidiform mole and subsequent pregnancy outcome following complete or partial hydatidiform molar pregnancy. BJOG. 2003; 110:22-26 (Pubitemid 36034289)
18. Van den Veyver IB, Al-Hussaini TK. Biparental hydatidiform moles: a maternal effect mutation affecting imprinting in the offspring. Hum Reprod Update. 2006;12:233-242
19. Wielsma S, Kerkmeijer L, Bekkers R, et al. Persistent trophoblast disease following partial molar pregnancy. Aust N Z J Obstet Gynaecol. 2006;46:119-123
20. Zaragoza MV, Surti U, Redline RW, et al. Parental origin and phenotype of triploidy in spontaneous abortions: predominance of diandry and association with the partial hydatidiform mole. Am J Hum Genet. 2000;66:1807-1820 (Pubitemid 30480088)